GMT Capital

Saturn Oil & Gas Inc is a Canada-based company involved in the exploration and development of oil and natural gas resources. The company specializes in acquiring undervalued, low-risk assets primarily in Alberta and Saskatchewan. Its portfolio includes properties such as Lucky Hills, which features the Viking Formation near Kindersley, and Flaxcombe, located approximately 30 kilometers west of Kindersley. Saturn Oil & Gas generates most of its revenue through the sale of oil, natural gas, and natural gas liquids, primarily operating under variable price contracts. The company aims to advance the exploration and production of its energy assets in these regions.

NewAmsterdam Pharma, established in 2019 and headquartered in Naarden, the Netherlands, is a late-stage biopharmaceutical company dedicated to improving patient care in cardio-metabolic disease populations. The company's primary focus is the development of transformative therapies, with its lead product, obicetrapib, being a next-generation, oral, low-dose CETP inhibitor designed to lower LDL-C levels more effectively than current treatments, particularly for patients with statin intolerance or Arteriosclerotic Cardiovascular Disease/Familial Hypercholesterolemia (ASCVD/FH) on maximally-tolerated statin therapy.

AlloVir, Inc. is a clinical-stage cell therapy company based in Cambridge, Massachusetts, specializing in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies aimed at preventing and treating serious viral-associated diseases. The company's lead product, Viralym-M, targets multiple viruses including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. Additionally, AlloVir is advancing several product candidates through preclinical and clinical stages, such as ALVR106 for respiratory syncytial virus and influenza, ALVR109 for SARS-CoV-2, ALVR107 for hepatitis B, and ALVR108 for human herpesvirus-8. The company, originally founded in 2013 as ViraCyte, Inc., rebranded to AlloVir in May 2019 and is committed to addressing the urgent medical needs of patients with limited treatment options for viral diseases.

Bigpoint GmbH, established in 2002 and headquartered in Hamburg, Germany, with additional offices in Berlin, San Francisco, and Malta, is a prominent developer and publisher of online and mobile games. The company is renowned for its high-quality browser-based games, catering to a wide audience through a "free-to-play, voluntary payment" business model. Bigpoint's portfolio spans casual to complex, long-term multiplayer games, setting industry standards in technology, gameplay, and entertainment. As a publisher, it promotes games that meet its stringent quality standards. With over 500 employees, Bigpoint has been recognized for its success with awards such as the Red Herring 100 Europe and the Eco Internet Award. In 2008, GMT and Peacock Equity, NBC Universal's capital fund, acquired a majority stake in the company.

XAware is an open-source data integration vendor that specializes in creating composite data services. The company offers a suite of tools, including XAware Designer, an Eclipse plug-in that facilitates the design, testing, and deployment of standards-compliant web services and data integration applications. Its XAware Engine enables the management of concurrent web services, while various connectors and adapters help users access and integrate data across applications and business processes. XAware’s solutions are designed to transform data into reusable services for real-time integration, supporting service-oriented architecture and rich Internet applications. The platform adheres to key technical and industry standards, allowing for seamless integration in diverse environments.